As of 2024-12-12, the Relative Valuation of Spero Therapeutics Inc (SPRO) is 4.43 USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.15 USD, the upside of Spero Therapeutics Inc based on Relative Valuation is 285.7%.
The range of the Relative Valuation is 1.39 - 7.36 USD.
| Range | Selected | |
| Trailing P/E multiples | 21.6x - 31.4x | 26.5x |
| Forward P/E multiples | 19.1x - 20.1x | 19.6x |
| Fair Price | 1.39 - 7.36 | 4.43 |
| Upside | 20.9% - 540.0% | 285.7% |
| Date | P/E |
| 2024-11-21 | 18.47 |
| 2024-11-20 | 18.62 |
| 2024-11-19 | 18.00 |
| 2024-11-18 | 17.69 |
| 2024-11-15 | 18.31 |
| 2024-11-14 | 19.40 |
| 2024-11-13 | 20.33 |
| 2024-11-12 | 20.49 |
| 2024-11-11 | 20.64 |
| 2024-11-08 | 20.49 |
| 2024-11-07 | 20.33 |
| 2024-11-06 | 20.33 |
| 2024-11-05 | 20.33 |
| 2024-11-04 | 20.02 |
| 2024-11-01 | 18.31 |
| 2024-10-31 | 19.09 |
| 2024-10-30 | 20.02 |
| 2024-10-29 | 20.33 |
| 2024-10-28 | 20.02 |
| 2024-10-25 | 20.64 |
| 2024-10-24 | 19.55 |
| 2024-10-23 | 19.55 |
| 2024-10-22 | 19.71 |
| 2024-10-21 | 19.86 |
| 2024-10-18 | 19.86 |
| 2024-10-17 | 19.94 |
| 2024-10-16 | 19.24 |
| 2024-10-15 | 18.62 |
| 2024-10-14 | 19.09 |
| 2024-10-11 | 19.40 |
| 2024-10-10 | 19.24 |
| 2024-10-09 | 19.24 |
| 2024-10-08 | 19.24 |
| 2024-10-07 | 20.18 |
| 2024-10-04 | 20.18 |
| 2024-10-03 | 20.02 |
| 2024-10-02 | 20.33 |
| 2024-10-01 | 20.33 |
| 2024-09-30 | 20.80 |
| 2024-09-27 | 20.33 |
| 2024-09-26 | 19.86 |
| 2024-09-25 | 19.86 |
| 2024-09-24 | 19.86 |
| 2024-09-23 | 20.18 |
| 2024-09-20 | 20.64 |
| 2024-09-19 | 21.03 |
| 2024-09-18 | 20.80 |
| 2024-09-17 | 20.64 |
| 2024-09-16 | 21.26 |
| 2024-09-13 | 21.26 |